Sort by
Refine Your Search
-
Category
-
Field
-
to tumors before and during therapy. (3) Use genetic and temporal pharmacologic approaches to modulate tumor biology in ways that enhance tumor binding of antibody- and non-antibody-based cancer therapies. (4
-
, Division of Oncology, specializing in Natural Killer Cell Biology. The Fehniger Lab is seeking a postdoctoral researcher to work on NK cell biology and NK cell therapy. We seek to understand basic mechanisms
-
Postdoctoral Research Associate (Genomics, Data Integration, Deep Learning, AI) - Radiation Oncology
an ambitious interest in developing tools and applying cutting-edge bioinformatic and deep learning/AI techniques to advance our understanding of cancer biology and treatment. Our agile, growing
-
Scheduled Hours 40 Position Summary The Schwarz Laboratory within the Cancer Biology Division and Department of Radiation Oncology at the Washington University School of Medicine in St. Louis, USA
-
Scheduled Hours 40 Position Summary The Fehniger Lab is seeking a candidate to work on NK cell biology and NK cell therapy. We seek to understand basic mechanisms of NK cell immune surveillance in
-
a cover letter and current curriculum vitae. Preferred Qualifications Highly motivated and passionate researcher with a M.D. or Ph.D. degree and rigorous training in immunology, cancer biology
-
therapy. The candidate will have the opportunity to engage in research across a broad range of fields including stem cell biology, immunology, cancer biology, and cell and gene therapy according
-
Scheduled Hours 40 Position Summary There is a research opportunity in the laboratory of David H. Gutmann, MD, PhD, director of the Washington University Neurofibromatosis Center. We are looking
-
, intellectual excitement, artistic pursuits and natural beauty. The Department of Radiation Oncology is an integral part of the Cancer Program at the University of Washington and a major contributor to the
-
Scheduled Hours 40 Position Summary As a curiosity-driven cancer biology lab, we are broadly interested in uncovering novel cancer targets with the overarching goal of improving patient outcome